Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 6Observational 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Colorectal Neoplasms 30Carcinoma, Non-Small-Cell Lung 9Breast Neoplasms 7Carcinoma, Renal Cell 6Carcinoma, Hepatocellular 6Lung Neoplasms 5Ovarian Neoplasms 4Colorectal Cancer Metastatic 3Colonic Neoplasms 3Adenocarcinoma of Lung 3Rectal Neoplasms 2Neoplasms 2Neoplasm Metastasis 2Liver Neoplasms 2Financial Stress 2Brain Neoplasms 2Adenocarcinoma, Bronchiolo-Alveolar 2Unspecified Adult Solid Tumor, Protocol Specific 1Unresectable Hepatocellular Carcinoma 1Surgical Wound Infection 1Non-Squamous Non-Small Cell Lung Cancer 1Neuroma, Acoustic 1Neurofibromatosis 2 1NSCLC 1Melanoma 1Kidney Neoplasms 1Hypertension 1Hemorrhage 1Glioblastoma 1Feasibility 1

Interventions

alovudine 1Tomography, Emission-Computed 1Positron-Emission Tomography 1Platelet Aggregation 1Magnetic Resonance Imaging 1Bleeding Time 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Unspecified Adult Solid Tumor, Protocol Specific × Bevacizumab × Clear all
NCT00898794 2013-08-07

Effect of Bevacizumab and VEGF on Platelet Clustering in Patients Who Are Receiving Bevacizumab for Cancer

National Cancer Institute (NCI)

Unknown
20 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡